PL308671A1 - Derivatives of 5-hydrazine quinolone exhibiting anti-microbial activity - Google Patents

Derivatives of 5-hydrazine quinolone exhibiting anti-microbial activity

Info

Publication number
PL308671A1
PL308671A1 PL93308671A PL30867193A PL308671A1 PL 308671 A1 PL308671 A1 PL 308671A1 PL 93308671 A PL93308671 A PL 93308671A PL 30867193 A PL30867193 A PL 30867193A PL 308671 A1 PL308671 A1 PL 308671A1
Authority
PL
Poland
Prior art keywords
quinolone
hydrazine
derivatives
microbial activity
exhibiting anti
Prior art date
Application number
PL93308671A
Other versions
PL178094B1 (en
Inventor
Thomas Prosser Demuth Jr
Ronald Eugene White
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of PL308671A1 publication Critical patent/PL308671A1/en
Publication of PL178094B1 publication Critical patent/PL178094B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PL93308671A 1992-10-30 1993-10-22 Derivatives of 5-hydrazine quinolone exhibiting anti-microbial activity PL178094B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96896092A 1992-10-30 1992-10-30
PCT/US1993/010091 WO1994010163A1 (en) 1992-10-30 1993-10-22 Antimicrobial 5-hydrazino-quinolone derivatives

Publications (2)

Publication Number Publication Date
PL308671A1 true PL308671A1 (en) 1995-08-21
PL178094B1 PL178094B1 (en) 2000-02-29

Family

ID=25514997

Family Applications (1)

Application Number Title Priority Date Filing Date
PL93308671A PL178094B1 (en) 1992-10-30 1993-10-22 Derivatives of 5-hydrazine quinolone exhibiting anti-microbial activity

Country Status (21)

Country Link
EP (1) EP0666853A1 (en)
JP (1) JPH08502750A (en)
KR (1) KR950704301A (en)
CN (1) CN1064357C (en)
AU (1) AU687018B2 (en)
BR (1) BR9307347A (en)
CA (1) CA2148003A1 (en)
CZ (1) CZ282581B6 (en)
EG (1) EG20543A (en)
FI (1) FI952049A (en)
HU (1) HUT72072A (en)
IL (1) IL107323A (en)
MX (1) MX9306814A (en)
NO (1) NO951640L (en)
NZ (1) NZ257470A (en)
PL (1) PL178094B1 (en)
RU (1) RU2126000C1 (en)
SG (1) SG59979A1 (en)
SK (1) SK54795A3 (en)
WO (1) WO1994010163A1 (en)
ZA (1) ZA938089B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646163A (en) * 1992-10-30 1997-07-08 The Procter & Gamble Company Quinolone 5-(N-heterosubstituted amino) antimicrobials
ATE190972T1 (en) * 1994-08-02 2000-04-15 Procter & Gamble METHOD FOR PRODUCING ANTIMICROBIAL COMPOUNDS
EP0775145A1 (en) * 1994-08-02 1997-05-28 The Procter & Gamble Company Process for making quinolonyl lactam antimicrobials and novel intermediate compounds
CA2242242C (en) * 1996-02-09 2001-08-07 Toyama Chemical Co., Ltd. Quinolonecarboxylic acid derivatives or salts thereof
US8524734B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
PT1901749T (en) * 2005-05-18 2016-11-04 Raptor Pharmaceuticals Inc Aerosolized fluoroquinolones and uses thereof
EE05697B1 (en) 2005-06-08 2014-02-17 Janssen Pharmaceutica N.V. Quinoline derivatives as antibacterial agents
EA010601B1 (en) * 2005-06-09 2008-10-30 Янссен Фармацевтика Н.В. Quinoline derivatives as antibacterial agents
CN101020647B (en) * 2007-02-14 2011-03-30 杭州师范学院 Synthesis process of beta-cyclopropylamino acrylate
US8063066B2 (en) 2007-03-19 2011-11-22 Takeda Pharmaceutical Company Limited MAPK/ERK kinase inhibitors
DK3092901T3 (en) * 2007-10-05 2020-05-18 Senhwa Biosciences Inc QUINOLON ANALOGS AND PROCEDURES RELATED
MX2010012855A (en) * 2008-06-03 2010-12-21 Actelion Pharmaceuticals Ltd [4-(1-amino-ethyl) -cyclohexyl] -methyl-amine and [6-(1-amino-ethyl) -tetrahydro- pyran-3-yl] -methyl-amine derivatives as antibacterials.
ES2809177T3 (en) 2008-10-07 2021-03-03 Horizon Orphan Llc Inhalation of levofloxacin to reduce lung inflammation
JP2012505223A (en) 2008-10-07 2012-03-01 エムペックス・ファーマシューティカルズ・インコーポレーテッド Aerosol fluoroquinolone formulation for improved pharmacokinetics
AR076222A1 (en) * 2009-04-09 2011-05-26 Actelion Pharmaceuticals Ltd DERIVATIVES 2-HYDROXIETIL-1H-QUINOLIN-ONA AND ITS AZAISOTHERAL ANALOGS WITH ANTIBACTERIAL ACTIVITY AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
CA2773033C (en) 2009-09-04 2016-10-11 Mpex Pharmaceuticals, Inc. Use of aerosolized levofloxacin for treating cystic fibrosis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668680A (en) * 1985-12-12 1987-05-26 Warner-Lambert Company 5-amino-6,8-difluoroquinolones as antibacterial agents
JPH0228178A (en) * 1988-04-23 1990-01-30 Toyama Chem Co Ltd Novel pyridonecarboxylic acid derivative and salt thereof
DE3906365A1 (en) * 1988-07-15 1990-01-18 Bayer Ag 7- (1-PYRROLIDINYL) -3-CHINOLONE AND NAPHTHYRIDONE CARBOXYLIC ACID DERIVATIVES, METHOD AND SUBSTITUTED (OXA) DIAZABICYCLOOCTANES AND NONANESE AS INTERMEDIATE PRODUCTS, AND ANTIBACTERIAL AGENTS AND FOOD ADDITIVES CONTAINING THEM
IE66202B1 (en) * 1989-08-16 1995-12-13 Pfizer Azabicyclo quinolone carboxylic acids
JPH05506033A (en) * 1990-04-18 1993-09-02 ノーウィッチ、イートン、ファーマスーティカルズ、インコーポレーテッド Antimicrobial quinolonyl lactams
WO1992009596A1 (en) * 1990-11-30 1992-06-11 Warner-Lambert Company Individual stereoisomers of 7-[3-(1-aminoalkyl)-1-pyrrolidinyl]-quinolones and naphthyridones as antibacterial agents

Also Published As

Publication number Publication date
MX9306814A (en) 1994-07-29
CA2148003A1 (en) 1994-05-11
ZA938089B (en) 1994-06-07
SK54795A3 (en) 1995-12-06
BR9307347A (en) 1999-05-25
HUT72072A (en) 1996-03-28
PL178094B1 (en) 2000-02-29
NZ257470A (en) 1997-08-22
EG20543A (en) 1999-07-31
KR950704301A (en) 1995-11-17
NO951640D0 (en) 1995-04-28
AU687018B2 (en) 1998-02-19
SG59979A1 (en) 1999-02-22
IL107323A (en) 2000-06-01
FI952049A0 (en) 1995-04-28
RU95110762A (en) 1997-01-10
CN1064357C (en) 2001-04-11
JPH08502750A (en) 1996-03-26
NO951640L (en) 1995-06-30
IL107323A0 (en) 1994-01-25
WO1994010163A1 (en) 1994-05-11
FI952049A (en) 1995-04-28
CN1092773A (en) 1994-09-28
EP0666853A1 (en) 1995-08-16
HU9501237D0 (en) 1995-06-28
RU2126000C1 (en) 1999-02-10
CZ282581B6 (en) 1997-08-13
CZ109795A3 (en) 1995-12-13
AU5409794A (en) 1994-05-24

Similar Documents

Publication Publication Date Title
HU9300034D0 (en) Derivatives of quinolone and of naphtyridone-carboxylic acid
GB9108547D0 (en) Quinoline derivatives
IL107377A0 (en) Carboxamide derivatives
ZA918539B (en) Indane and quinoline derivatives
EG19861A (en) Novel antimicrobial quinolone thioureas
PL308671A1 (en) Derivatives of 5-hydrazine quinolone exhibiting anti-microbial activity
SG44523A1 (en) Quinoline derivatives
IL107188A0 (en) Derivatives of quinolonecarboxylic acid and naphthyridonecarboxylic acid, their preparation and antibacterial compositions containing them
NZ215868A (en) Substituted naphthyridine and quinoline derivatives as antibacterial agents
ZA93826B (en) 7-Substituted quinolones and naphthyridones as antibacterial agents
NO930520D0 (en) BIFENYL-SUBSTITUTED QUINOLINE DERIVATIVES
IL98833A0 (en) Preparation of quinoline derivatives
HU9301758D0 (en) Isoquinoline derivatives of fungicidal effect
IL107706A0 (en) Fungicidal derivatives of 2-alkoxy-2-imidazolin-5-ones
BR9205939A (en) Derivatives of 4-aryl-3- (heteroalylureido) quinoline
HU9500632D0 (en) Antipsychotic quinoline derivatives of benzodioxanmethylamine
SK4695A3 (en) Quinoline and naphthyridine derivatives and antibacterial agent on their basis
ZA912717B (en) Quinolinecarboxylic acid antibacterial agents
GB9126438D0 (en) New quinoline derivatives
ZA932678B (en) New azetidine derivatives of pyridonecarboxylic acids with antimicrobial activity
GB9201427D0 (en) Quinoline derivatives
PL292553A1 (en) Derivatives of 4(1h) quinolone
ZA896607B (en) Quinolone derivatives with antibacterial activity
IL105076A0 (en) Quinolone disulfide
IE901869L (en) Quinoline derivatives